01.12.2018 | Research | Ausgabe 1/2018 Open Access

Comparison of exercise intensity during four early rehabilitation techniques in sedated and ventilated patients in ICU: a randomised cross-over trial
- Zeitschrift:
- Critical Care > Ausgabe 1/2018
Background
Method
Design
Patients
Procedure and randomisation
Measures
Primary endpoint
Secondary endpoints
Statistical analysis
Results
Characteristics
|
Value (
N = 19 patients)
|
---|---|
Female,
n (%)
|
6 (32)
|
Age, mean (SD)
|
65.3 (9.7)
|
Body mass index (kg/m
2), median (25–75th percentile)
|
29.7 (22.5–32.7)
|
SAPS II at ICU admission, mean (SD)
|
57.5 (24)
|
Main diagnosis
|
|
Pneumonia,
n (%)
|
4 (21)
|
Sepsis,
n (%)
|
1 (5)
|
COPD/asthma exacerbation,
n (%)
|
1 (5)
|
Cardiac failure,
n (%)
|
3 (16)
|
Drug overdose/acute mental status change,
n (%)
|
5 (26)
|
Intra-abdominal sepsis with surgery,
n (%)
|
5 (26)
|
Co-morbidity
|
|
Chronic pulmonary disease,
n (%)
|
6 (32)
|
Obesity,
n (%)
|
9 (47)
|
Chronic cardiac insufficiency,
n (%)
|
5 (26)
|
Cancer,
n (%)
|
1 (5)
|
Chronic kidney disease,
n (%)
|
3 (16)
|
Diabetes mellitus,
n (%)
|
7 (37)
|
Between admission and inclusion
|
|
Septic shock,
n (%)
|
6 (31)
|
ARDS,
n (%)
|
5 (26)
|
Renal failure,
n (%)
|
8 (42)
|
Use of cathecolamines,
n (%)
|
13 (68)
|
Use of neuromuscular blockers,
n (%)
|
10 (53)
|
No. of days of neuromuscular blockers, median (25–75th percentile)
|
1 (0–2)
|
Ventilator use (days), median (25–75th percentile)
|
4 (2–7)
|
Ventilator parameters and sedation use during protocol
|
|
Pressure support (cmH
2O), mean (SD)
|
15 (3)
|
Positive end-expiratory pressure (cmH
2O), mean (SD)
|
7 (1)
|
Fraction of inspired oxygen (%), mean (SD)
|
35 (13)
|
Midazolam mg/h, mean (SD)
|
5 (4)
|
Primary outcome
Cardiac output
(L/min) (95% CI)
|
Passive range of leg motion (PROM)
|
Passive cycle-ergometery
|
Quadriceps electrical stimulation
|
Functional electrical stimulation cycling (FES cycling)
|
---|---|---|---|---|
Rest
|
6.6 (5.6–7.3)
|
6.7 (5.8–7.7)
|
6.6 (5.7–7.6)
|
6.7 (5.7–7.6)
|
3 min
|
6.6 (5.6–7.5)
|
6.8 (5.8–7.8)
|
6.8 (5.8–7.7)
|
7.3 (6.3–8.3)
*, ‡
|
6 min
|
6.5 (5.5–7.5)
|
6.8 (5.8–7.7)
|
6.7 (5.8–7.7)
|
7.7 (6.8–8.7)
*, †,‡
|
9 min
|
6.5 (5.6–7.5)
|
6.8 (5.8–7.7)
|
6.8 (5.8–7.7)
|
7.7 (6.7–8.7)
*, †,‡
|
Recovery
|
6.6 (5.6–7.5)
|
6.7 (5.7–7.6)
|
6.6 (5.7–7.6)
|
7.1 (6.2–8.1)
*
|
Secondary outcomes
Outcomes
|
PROM
|
Passive cycle ergometry
|
Quadriceps electrical stimulation
|
FES cycling
|
||||
---|---|---|---|---|---|---|---|---|
Rest
|
Exercise
|
Rest
|
Exercise
|
Rest
|
Exercise
|
Rest
|
Exercise
|
|
Heart rate (b/min)
|
93 (86–100)
|
93 (86–100)
|
94 (86–101)
|
94 (86–101)
|
94 (86–101)
|
93 (86–101)
|
94 (86–101)
|
97
* (90–104)
|
TAPSE (cm)
|
2 (1.8–2.2)
|
1.9 (1.7–2.1)
|
1.8 (1.5–2)
|
1.8 (1.6–2)
|
1.7 (1.5–2)
|
1.8 (1.6–2)
|
1.8 (1.6–2)
|
2
* (1.8–2.2)
|
Mean arterial pressure (mmHg)
|
87 (80–93)
|
88 (82–94)
|
85 (79–91)
|
89
* (83–95)
|
87 (80–93)
|
87 (81–93)
|
84 (77–90)
|
91
* (85–97)
|
PAPS (mmHg)
|
51 (37–66)
|
45 (32–59)
|
51 (39–63)
|
49 (35–62)
|
47 (35–58)
|
46 (35–57)
|
50 (36–64)
|
51
†,‡ (36–67)
|
Respiratory Rate (c/min)
|
20 (16–24)
|
20 (16–24)
|
22 (17–27)
|
22 (17–27)
|
20 (15–25)
|
21 (16–26)
|
21 (17–25)
|
24
†,‡ (19–30)
|
Tidal volume (mL)
|
513 (447–579)
|
507 (443–571)
|
514 (427–600)
|
527 (449–605)
|
521 (446–596)
|
497 (441–553)
|
510 (427–593)
|
521 (446–596)
|